Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$562000.0.

  • GeneDx Holdings' Interest & Investment Income rose 3333.33% to -$562000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 1796.5%. This contributed to the annual value of -$3.0 million for FY2024, which is 37217.24% down from last year.
  • Per GeneDx Holdings' latest filing, its Interest & Investment Income stood at -$562000.0 for Q3 2025, which was up 3333.33% from -$817000.0 recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Interest & Investment Income peaked at $1.1 million during Q4 2022, and registered a low of -$978000.0 during Q4 2023.
  • Moreover, its 5-year median value for Interest & Investment Income was $21000.0 (2021), whereas its average is -$28947.4.
  • Per our database at Business Quant, GeneDx Holdings' Interest & Investment Income soared by 506363.64% in 2022 and then tumbled by 18609.15% in 2023.
  • GeneDx Holdings' Interest & Investment Income (Quarter) stood at $22000.0 in 2021, then skyrocketed by 5063.64% to $1.1 million in 2022, then tumbled by 186.09% to -$978000.0 in 2023, then rose by 28.63% to -$698000.0 in 2024, then increased by 19.48% to -$562000.0 in 2025.
  • Its last three reported values are -$562000.0 in Q3 2025, -$817000.0 for Q2 2025, and -$640000.0 during Q1 2025.